Navigation Links
Accelrys Advances Biology Innovation with New Release of Assay and Study Management Product Suite
Date:11/7/2013

SAN DIEGO, Nov. 7, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, has announced the latest release of its unified biology assay and study management software suite consisting of Accelrys BioRails DM 4.5, Accelrys BioRails PTO 4.5 and Accelrys Morphit 3.0. The Accelrys BioRails assay data management and project tracking/optimization applications together with the powerful Morphit spreadsheet application help improve the efficiency and productivity of research and development scientists engaged in early-stage screening through in vitro ADME, in vivo DMPK and pharmacology experiments. In the latest BioRails releases, deeper integration with the Accelrys Enterprise Platform and Accelrys Pipeline Pilot extends the data processing and reporting capabilities of BioRails, significantly improving personal and project team productivity in bringing new drugs to market.

"Coordinating and tracking study designs for lead optimization of small molecule and biotherapeutics drugs is a challenge today that leads to inefficient delivery of results, slow turnaround times, costly bottlenecks and poor decision transparency across organizational and geographic boundaries," said Adel Laoui, PhD, managing director of the Accelrys Life Sciences R&D segment. "The latest releases of the Accelrys BioRails and Morphit applications offer a comprehensive, scalable software solution with true integration of different biopharmaceutical data types, enabling scientists to efficiently manage, analyze and share structured bioassay data during multi-domain drug optimization."

Accelrys BioRails DM (Data Management) and Accelrys BioRails PTO (Project Tracking and Optimization) offer a comprehensive, extensible solution for capturing, processing, analyzing and reporting low to medium-throughput in vitro and in vivo biological data and associated workflows. Through integration with the Accelrys Electronic Lab Notebook and the Accelrys Chemical Registration applications, BioRails enables research scientists and project teams to capture experimental data and methodologies together in a single system, enabling them to quickly analyze assay results and refine study designs. New features in Accelrys BioRails 4.5 include:

  • Integration with the Accelrys Enterprise Platform and Scientific Component Collections improve access to scientific solutions across different domains.
  • Configurable linking enables integration to external data processing engines including the Accelrys Pipeline Pilot scientific workflow authoring application, enabling project teams to save time by automating tedious manual tasks and sharing best-practice workflows.
  • New color-coding of workflows enables project managers to track the status of work in progress and prioritize jobs across teams and individuals.
  • Enhanced email notifications support the strategic flow of information and tactical coordination of tasks in a collaborative research environment.

A key component of the BioRails DM application, Accelrys Morphit is a richly interactive, multidimensional Windows client for spreadsheet data capture, analysis and reporting across a wide range of experiments from plate-based in vitro screening to in vivo behavioral studies. As well as providing a significantly enhanced user interface with drag-and-drop selection capabilities, Accelrys Morphit 3.0 offers the following new features, accelerating data capture and analysis in molecular/experimental biology:

  • Out-of-the-box pharmacokinetics tools incorporating industry-standard formulas for calculating area under curve, clearance, half life and other PK parameters, enabling fast, flexible PK template design
  • Enhanced charting capabilities enabling advanced visualization for improved decision making
  • Tighter integration with Microsoft Excel® spreadsheets for improved performance and usability
  • New statistical tests for in vivo profiling for greater confidence in results using functions validated against industry standards

To learn more about Accelrys BioRails 4.5 and Accelrys Morphit 3.0, visit Accelrys at booth 1211 at the AAPS Annual Meeting and Exposition, Nov. 10 to 14, in San Antonio, TX, or register for a complimentary webinar entitled "What's New in Biological Innovation: the Accelrys Assay and Study Management Product Suite" to be held on Tuesday, Dec. 3, 8 – 9 a.m. PST.                

About Accelrys, Inc.
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad and flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

Accelrys solutions are used by more than 1,300 companies in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, California, USA, Accelrys employs more than 200 full-time PhD scientists. For more information about Accelrys, visit www.accelrys.com.

 

 

Related Links:
Download Case Study: Evotec 
BioRails PTO Datasheet 
BioRails DM Datasheet 
Morphit Datasheet 
Accelrys Website 
Friend Accelrys on Facebook 
Follow Accelrys on Twitter 
Connect with Accelrys on LinkedIn 
Accelrys' YouTube Channel

Video with caption: "Video: An Overview of BioRails". Video available at: http://www.youtube.com/watch?v=n-yeaIPuH78

Image with caption: "Hepatic Clearance: Summary table showing clearance data for a selection of compounds in a hepatic clearance study in Accelrys Morphit." Image available at: http://photos.prnewswire.com/prnh/20131107/MM13018-a

Image with caption: "Compound Order: Reviewing the status of a compound lot queue in BioRails PTO." Image available at: http://photos.prnewswire.com/prnh/20131107/MM13018-b

Image with caption: "Accelrys, Inc. Logo." Image available at: http://photos.prnewswire.com/prnh/20120416/MM88629LOGO


'/>"/>
SOURCE Accelrys, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Accelrys Materials Studio Release 6.1 Speeds Innovation with Enterprise Capabilities
2. Accelrys Announces Strategic Partnership with USDM
3. Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software for Improved Quality Control and Regulatory Compliance
4. Accelrys Transforms Innovation by Bridging Cheminformatics and Bioinformatics
5. Accelrys Brings Industry Leaders Together at Life Sciences Symposium
6. Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
7. Nabsys to Present DNA Sequence Data from Solid-State Nanodetectors at the Annual Advances in Genome Biology and Technology (AGBT) Meeting and the EMBL Omics and Personalized Health Conference
8. UWM discovery advances graphene-based electronics
9. Next-generation nanoelectronics: A decade of progress, coming advances
10. New metamaterial practical for optical advances
11. Biodetection 2012 Conference Brings Together Leading Organizations from Around the World to Address Challenges & Technology Advances in Detection and Identification of Biological Threats in Washington, DC from June 28-29, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... has joined STACS DNA as a Field Application Specialist. , “I am thrilled ... COO of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays ...
Breaking Biology Technology:
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... Systems, Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & ... intelligence provider visiongain offers comprehensive analysis of ... that this market will generate revenues of $17.98 billion ... Systems acquired DVTEL Inc, a leader in software and ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
Breaking Biology News(10 mins):